Latest

Causation

Home Causation

Causation

Hong Kong Breast Cancer Study: Most Cases Not Hereditary

September 22, 2018

Biofourmis Collaborates with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation...

July 18, 2019

Biologics Associated with 34,000 Deaths Since 2004: What Are the Implications?

July 18, 2019

MD Anderson Shows Enrollment on Genomically Matched Clinical Trial Improves Sarcoma Outcomes

July 18, 2019

Former NIH Director on U.S. Authorities Targeting of Chinese Researchers

July 18, 2019

TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

159 West Broadway Suite 200
Salt Lake City, UT 84101
Contact us: admin@trialsitenews.com

Privacy Policy

Contact

© TrialSite News, Inc. All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok

Edit with Live CSS

Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.

Hong Kong Breast Cancer Study: Most Cases Not Hereditary

EDITOR PICKS

Biofourmis Collaborates with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation...

Biologics Associated with 34,000 Deaths Since 2004: What Are the Implications?

MD Anderson Shows Enrollment on Genomically Matched Clinical Trial Improves Sarcoma Outcomes

Former NIH Director on U.S. Authorities Targeting of Chinese Researchers